These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23408152)

  • 1. In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines.
    Fiorentino M; Lammers KM; Levine MM; Sztein MB; Fasano A
    Front Immunol; 2013; 4():17. PubMed ID: 23408152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of
    Salerno-Gonçalves R; Galen JE; Levine MM; Fasano A; Sztein MB
    Front Immunol; 2018; 9():2543. PubMed ID: 30443257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral typhoid vaccine Ty21a elicits antigen-specific resident memory CD4
    Booth JS; Goldberg E; Barnes RS; Greenwald BD; Sztein MB
    J Transl Med; 2020 Feb; 18(1):102. PubMed ID: 32098623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Oral Typhoid Vaccine Ty21a Elicits Lamina Propria and Intra-Epithelial Lymphocyte Tissue-Resident Effector Memory CD8 T Responses in the Human Terminal Ileum.
    Booth JS; Patil SA; Goldberg E; Barnes RS; Greenwald BD; Sztein MB
    Front Immunol; 2019; 10():424. PubMed ID: 30923521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release.
    Fiorentino M; Levine MM; Sztein MB; Fasano A
    PLoS One; 2014; 9(1):e85211. PubMed ID: 24416363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans.
    Booth JS; Patil SA; Ghazi L; Barnes R; Fraser CM; Fasano A; Greenwald BD; Sztein MB
    Cell Mol Gastroenterol Hepatol; 2017 Nov; 4(3):419-437. PubMed ID: 29022005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A; Pakkanen SH; Karttunen R; Kantele JM
    PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Goncalves R; Pasetti MF; Sztein MB
    J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of RpoS
    Burda WN; Brenneman KE; Gonzales A; Curtiss R
    mSphere; 2018; 3(1):. PubMed ID: 29507892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
    Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB
    Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the live oral attenuated typhoid vaccine, Ty21a, on systemic and terminal ileum mucosal CD4+ T memory responses in humans.
    Booth JS; Goldberg E; Patil SA; Barnes RS; Greenwald BD; Sztein MB
    Int Immunol; 2019 Feb; 31(2):101-116. PubMed ID: 30346608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.
    Salerno-Gonçalves R; Wyant TL; Pasetti MF; Fernandez-Viña M; Tacket CO; Levine MM; Sztein MB
    J Immunol; 2003 Mar; 170(5):2734-41. PubMed ID: 12594304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization.
    McArthur MA; Sztein MB
    PLoS One; 2012; 7(6):e38408. PubMed ID: 22679502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.
    Pasetti MF; Salerno-Gonçalves R; Sztein MB
    Infect Immun; 2002 Aug; 70(8):4009-18. PubMed ID: 12117906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.